These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 34233453)

  • 1. Viral shedding in symptomatic patients with mild COVID-19: an experience with nebulized nasal treatment.
    Varricchio A; La Mantia I; Brunese FP; Varricchio A; Ciprandi G
    J Biol Regul Homeost Agents; 2021; 35(3):1155-1157. PubMed ID: 34233453
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertonic saline with xylitol and hyaluronate may shorten the viral shedding duration in asymptomatic COVID-19 positive subjects: a pilot study.
    Ciprandi G; La Mantia I; Brunese FP; Varricchio A; Varricchio A
    J Biol Regul Homeost Agents; 2021; 35(3):1151-1154. PubMed ID: 34229425
    [No Abstract]   [Full Text] [Related]  

  • 3. Smell recovery in patients with COVID-19: an experience with nebulized nasal treatment.
    Varricchio A; La Mantia I; Brunese FP; Ciprandi G
    J Biol Regul Homeost Agents; 2021; 35(2):683-686. PubMed ID: 33728831
    [No Abstract]   [Full Text] [Related]  

  • 4. Nebulized Hypertonic Saline for Bronchiolitis.
    Roodsari G; Zehtabchi S
    Am Fam Physician; 2018 Jul; 98(1):23-24. PubMed ID: 30215960
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients.
    Chen Y; Li P; Ding Y; Liu M; Liu L; Yi B; Wu T; Dong H; Lao X; Ding K; Wang H; Zhang D; Tan X; Wang Z; Xu G; Cao G
    J Infect Public Health; 2021 Jul; 14(7):845-851. PubMed ID: 34118734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulized hypertonic saline containing hyaluronic acid improves tolerability in patients with cystic fibrosis and lung disease compared with nebulized hypertonic saline alone: a prospective, randomized, double-blind, controlled study.
    Furnari ML; Termini L; Traverso G; Barrale S; Bonaccorso MR; Damiani G; Piparo CL; Collura M
    Ther Adv Respir Dis; 2012 Dec; 6(6):315-22. PubMed ID: 22968159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).
    Xu K; Chen Y; Yuan J; Yi P; Ding C; Wu W; Li Y; Ni Q; Zou R; Li X; Xu M; Zhang Y; Zhao H; Zhang X; Yu L; Su J; Lang G; Liu J; Wu X; Guo Y; Tao J; Shi D; Yu L; Cao Q; Ruan B; Liu L; Wang Z; Xu Y; Liu Y; Sheng J; Li L
    Clin Infect Dis; 2020 Jul; 71(15):799-806. PubMed ID: 32271376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled Nebulized Sodium Pyruvate Use in COVID-19 Patients.
    Hidvégi M
    Isr Med Assoc J; 2020 May; 22(5):278. PubMed ID: 32378817
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.
    Wang K; Zhang X; Sun J; Ye J; Wang F; Hua J; Zhang H; Shi T; Li Q; Wu X
    Chest; 2020 Nov; 158(5):1876-1884. PubMed ID: 32569635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
    Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized hypertonic saline solution for acute bronchiolitis in infants.
    Zhang L; Mendoza-Sassi RA; Wainwright C; Klassen TP
    Cochrane Database Syst Rev; 2008 Oct; (4):CD006458. PubMed ID: 18843717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
    Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
    Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulized Therapy in the COVID-19 Era: The Right Tool for the Right Patient [Letter].
    Hess MW
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2101-2102. PubMed ID: 32982202
    [No Abstract]   [Full Text] [Related]  

  • 14. Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus Disease 2019: A Retrospective Study of 110 Children in Wuhan.
    Lu Y; Li Y; Deng W; Liu M; He Y; Huang L; Lv M; Li J; Du H
    Pediatr Infect Dis J; 2020 Jul; 39(7):e95-e99. PubMed ID: 32379191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
    Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
    BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study.
    Zhang X; Lu S; Li H; Wang Y; Lu Z; Liu Z; Lai Q; Ji Y; Huang X; Li Y; Sun J; Wu Y; Xu X; Hou J
    Virol Sin; 2020 Dec; 35(6):820-829. PubMed ID: 33351168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
    Li L; Liang Y; Hu F; Yan H; Li Y; Xie Z; Huang L; Zhao J; Wan Z; Wang H; Shui J; Cai W; Tang S
    Virology; 2020 Dec; 551():26-35. PubMed ID: 33011520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic and Asymptomatic Viral Shedding in Pediatric Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Under the Surface.
    DeBiasi RL; Delaney M
    JAMA Pediatr; 2021 Jan; 175(1):16-18. PubMed ID: 32857158
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature.
    Fontana LM; Villamagna AH; Sikka MK; McGregor JC
    Infect Control Hosp Epidemiol; 2021 Jun; 42(6):659-668. PubMed ID: 33077007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of viral shedding in asymptomatic or mild cases of novel coronavirus disease 2019 (COVID-19) from a cruise ship: A single-hospital experience in Tokyo, Japan.
    Miyamae Y; Hayashi T; Yonezawa H; Fujihara J; Matsumoto Y; Ito T; Tsubota T; Ishii K
    Int J Infect Dis; 2020 Aug; 97():293-295. PubMed ID: 32535295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.